Summary of Original Version

Amend KRS 304.17A-163 to permit insurers to require insureds to try biosimilar biological products prior to providing coverage for the equivalent branded prescription drug under certain circumstances; make findings and establish intent of Act.

Summary of Amendment: House Committee Substitute 1

Summary Amend KRS 304.17A-163 relating to construction of statute relating to step therapy protocols.

Summary of Amendment: House Committee Amendment 1 -- M. Meredith

Summary Make title amendment.